Illumina, Inc. (ILMN) stock prices updated...
 

Illumina, Inc. stock price

Illumina, Inc. latest news:


  • 01/26/2018 14:23:55

    BRIEF-Illumina Awarded $26.7 Mln In Patent Suit Against Ariosa Diagnostics

    Illumina Inc(ILMN): * ILLUMINA AWARDED $26.7M IN PATENT SUIT AGAINST ARIOSA DIAGNOSTICS, INC. * Illumina Inc(ILMN) - ‍FEDERAL JURY IN SAN FRANCISCO RULED IN CO'S FAVOR IN PATENT INFRINGEMENT SUIT FILED AGAINST ARIOSA DIAGNOSTICS, NOW OWNED BY ROCHE​ Source text for Eikon: Further company coverage:

  • 01/25/2018 13:48:40

    Illumina wins $26.7 million in patent fight with Roche unit Ariosa

    Jan 25 (Reuters) - Gene testing company Illumina on Thursday won a $26.7 million jury verdict in a U.S. lawsuit accusing rival Ariosa Diagnostics, a subsidiary of Roche Holdings AG, of using patented prenatal testing technology without authorization.

  • 01/11/2018 04:26:11

    BRIEF-Illumina Sees Non-GAAP Diluted EPS Attributable To Illumina Stockholders In Range Of $4.50-$4.60 For Fiscal Year ...

    Illumina Inc(ILMN): * Illumina Inc(ILMN) - SEES NON-GAAP DILUTED EPS ATTRIBUTABLE TO ILLUMINA STOCKHOLDERS IN RANGE OF $4.50 - $4.60 FOR FISCAL YEAR 2018. * ILLUMINA (ILMN) - SEES SEES GAAP DILUTED EPS ATTRIBUTABLE TO ILLUMINA STOCKHOLDERS IN RANGE OF $4.14 - $4.24 FOR FISCAL YEAR 2018- SEC FILING Source text: [http://bit.ly/2AObRYh] Further company coverage:

  • 12/27/2017 14:35:14

    BRIEF-HTG Molecular, Illumina Agreed To Third Development Plan Under Parties' Amended & Restated Development & Supply ...

    HTG Molecular Diagnostics Inc(HTGM): * HTG MOLECULAR DIAGNOSTICS(HTGM) - ON DEC 23, CO, ILLUMINA AGREED TO THIRD DEVELOPMENT PLAN UNDER PARTIES' AMENDED & RESTATED DEVELOPMENT & SUPPLY AGREEMENT. * HTG MOLECULAR DIAGNOSTICS SAYS UNDER PLAN, ILLUMINA EXPECTED TO DEVELOP & DELIVER TO CO EXECUTABLE VERSION OF CUSTOM SOFTWARE - SEC FILING Source text: Further company coverage:

  • 12/27/2017 14:35:00

    BRIEF-HTG Molecular, Illumina Agreed To Third Development Plan Under Parties' Amended & Restated Development & Supply Agreement

    * HTG MOLECULAR DIAGNOSTICS - ON DEC 23, CO, ILLUMINA AGREED TO THIRD DEVELOPMENT PLAN UNDER PARTIES' AMENDED & RESTATED DEVELOPMENT & SUPPLY AGREEMENT

  • More trends:

    Image Sensing Systems, Inc.ISNS | Immersion CorporationIMMR | ImmuCell CorporationICCC | Immune Design Corp.IMDZ | Immune Pharmaceuticals Inc.IMNP | ImmunoGen, Inc.IMGN | Immunomedics, Inc.IMMU | Impax Laboratories, Inc.IPXL | Imprimis Pharmaceuticals, Inc.IMMY | INC Research Holdings, Inc.INCR |